20:20 · 18 āļĄāļāļĢāļēāļ„āļĄ 2023

Moderna shares higher after RSV vaccine reports 💉📈

Moderna
āļŦāļļāđ‰āļ™
MRNA.US, Moderna Inc
-
-

Shares of Moderna (MRNA.US) are trading higher as the company relayed that its vaccine mRNA-1345 against RSV (respiratory syncytial virus) effectively prevents the development of the disease in older adults (phase III research vaccine development results).

  • The company expects to file for approval with the Food and Drug Administration (FDA) in the first half of this year.
  • Moderna shares are up nearly 8% before the Wall Street session and are trading around 205 USD. 

Moderna's shares have been in an uptrend since the company broke the news in the fall of 2022 that it was collaborating with Merck (MRK.US) on a promising anti-cancer therapy. The price on the H1 interval has climbed above the 100 (black line) and 200-session (red line) moving averages, and an opening above $200 could open a path for bulls toward the mid-December highs, when the stock was trading at $217 per share. Moderna will show Q4 2022 results on February 2.

Moderna shares (MRNA.US), H1 interval. Source: xStation5

3 āļ•āļļāļĨāļēāļ„āļĄ 2025, 08:21

āļŦāļļāđ‰āļ™āđ€āļ”āđˆāļ™āļ›āļĢāļ°āļˆāļģāļŠāļąāļ›āļ”āļēāļŦāđŒ – Quanta Services Inc.

3 āļ•āļļāļĨāļēāļ„āļĄ 2025, 08:14

DE40: āļĒāļļāđ‚āļĢāļ›āļāļģāļĨāļąāļ‡āļŸāļ·āđ‰āļ™āļ•āļąāļ§

2 āļ•āļļāļĨāļēāļ„āļĄ 2025, 15:10

Samsung āļžāļļāđˆāļ‡āļ‚āļķāđ‰āļ™ 4% āļ—āđˆāļēāļĄāļāļĨāļēāļ‡āļ”āļĩāļĨ OpenAI & āđ‚āļ„āļĢāļ‡āļāļēāļĢ Stargate āļ‚āļ­āļ‡āļŠāļŦāļĢāļąāļāļŊ 📈

2 āļ•āļļāļĨāļēāļ„āļĄ 2025, 08:27

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™āļ§āļąāļ™āļ™āļĩāđ‰: Wall Street āđƒāļāļĨāđ‰āļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āđ€āļ›āđ‡āļ™āļ›āļĢāļ°āļ§āļąāļ•āļīāļāļēāļĢāļ“āđŒ āđāļĄāđ‰āđ€āļœāļŠāļīāļ Government Shutdown

āđ€āļ‚āđ‰āļēāļŠāļđāđˆāļ•āļĨāļēāļ”āļžāļĢāđ‰āļ­āļĄāļĨāļđāļāļ„āđ‰āļēāļ‚āļ­āļ‡ XTB Group āļāļ§āđˆāļē 1 700 000 āļĢāļēāļĒ

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ